Nanoveu Limited announced that it has appointed Dr. Michael Winlo to its board as a Non-Executive Director. Dr. Michael Winlo has extensive experience in leading high-growth teams across the biotech, pharmaceutical and technology sectors, and is currently the Managing Director of Emyria Limited. Dr. Winlo is also a Director and former CEO of Linear Clinical Research, a world-class provider of early and late stage pharmceutical trials.

Prior to his role at Linear, Michael was based in Silicon Valley as the health lead for Palantir Technologies. There, Michael led deployments for health companies and government organizations across the US and UK. Dr. Winlo has a Master of Business Administration (MBA) from Stanford University and a Bachelor of Medicine, Bachelor of Surgery (MBBS) from the University of Western Australia.